key: cord-0959746-awebq53d
authors: Joseph, Betsy; CS, Prasanth
title: Is Photodynamic therapy a viable antiviral weapon against COVID-19 in Dentistry? Letter to the Editor
date: 2021-01-30
journal: Oral Surg Oral Med Oral Pathol Oral Radiol
DOI: 10.1016/j.oooo.2021.01.025
sha: 63c5be75763b5473ccf2e18dc022e3ba28569adc
doc_id: 959746
cord_uid: awebq53d

nan

With great interest, we read the recent article 1 that describes a series of eight cases of oral manifestations of COVID-19 and its management. In Case 1, photobiomodulation was applied as an adjunct for symptomatic relief of oral lesions. We would like to throw light on the viral load reduction of SARS-CoV-2 by photoactivation of the photosensitizer (PS) using a specific wavelength through peroxidation that could expand the scope of photodynamic therapy (PDT) in healthcare during this pandemic. SARS-CoV-2 has posed many challenges for healthcare professionals. The dental fraternity is among the worst affected sector following the COVID-19 pandemic. Oral manifestations such as ulcers, blisters, and vesiculobullous lesions 2-4 are often among the earliest manifestations of COVID-19 viral infections which have been managed by treatment modalities such as antifungal, topical or systemic corticosteroids, systemic antibiotics and systemic acyclovir to alleviate these symptoms.

However, there are no studies in Dentistry till date that reports the use of PDT to manage oral manifestations for COVID-19 although it has been earlier used in dental specialties such as Periodontics, Endodontics, Oral Medicine and Oral Surgery for managing periodontitis, halitosis, intra-canal disinfection, oral wound healing, herpes labialis etc. Previous works 5-7 by the authors of this letter demonstrate the efficacy of PDT in periodontal disease and it was tolerated well by the patients.

Based on PDT's effectiveness against influenza viruses, 8 few studies have proposed the benefits of PDT in lung lesions of COVID-19 cases. 1, 9 One of the theories states that photosensitization of viruses induces the glycoproteins removal from the viral surface, and the virus becomes virions non-infectious, thus without damage to the membrane. 8 It is interesting to note that PS such as Methylene blue (MB), Radachlorin, and 5-amino levulinic acid have shown high antiviral activity against SARS-CoV-2. 10,11 These PS molecules can also act by 'enticing' SARS-CoV-2 virions so that it would attach to these PS molecules instead of healthy oral tissue 12 or attack healthy haemoglobin. 1 Additionally, MB without photoactivation has been found to inactivate SARS-CoV-2 in vitro. 13 This makes MB a strong candidate in the management of COVID-19 lesions. Furthermore, MB has also been shown to inhibit the SARS-CoV-2 spike protein's protein-protein interaction and its receptor ACE2, a critical step 14 .

The distressful symptoms of oral pain, blister, and vesiculobullous lesions present in few symptomatic oral lesions in COVID-19 positive patients are attributed to the derangement in angiotensin-converting enzyme 2 (ACE-2) receptor, and the subsequently increased bradykinin activity as part of the kininogen-kallikrein system. 13 This could also be the reason for the dilation of blood vessels and swelling in these cases. Furthermore, it is speculated that an immunologic phenomenon known as "cytokine storm" occurs in COVID-19 as in the case of other viral diseases like Influenza. 15 This is a crucial finding as the (ACE 2) receptor is a known receptor for SARS-CoV-2. These receptors are found in oral mucosa, including the tongue and salivary glands' dorsum and would be responsible for many of the oral lesions in COVID-19 positive patients.

Therefore, based on the available scientific evidence, we propose that PDT is a viable weapon for preventing and treating oral manifestations of COVID-19. Along with alleviation of oral pain and discomfort in symptomatic patients, PDT can also be used to disinfect the oral cavity, periodontal pockets, and saliva in asymptomatic patients to manage the outbreak. Further, in vitro and clinical studies are needed to unleash the full potential of PDT that exerts antiviral and antimicrobial effects without the risk of drug resistance and other unwanted side effects. 

Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral surgery, oral medicine, oral pathology and oral radiology

Oral manifestations of COVID-19 disease: A review article